Cardioprotective effect of resveratrol and resveratroloside.

Cardiovasc Hematol Agents Med Chem 2013 Sep;11(3):207-10

Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 630090, Novosibirsk, Russia.

Cardioprotective effect of resveratrol and resveratroloside was determined in ischemia-reperfusion experiments on rats. It was found that single intraperitoneal administration of any compound (10 mg/kg) followed by 30-min ischemia and 120-min reperfusion resulted in statistically significant decrease of myocardial infarct area (55.0±4.0% for control group; 40.7±4.4% for the group 1 received resveratrol; 41.6±4.8% for the group 2 received resveratroloside). The cardioprotective effect of resveratroloside was detected for the first time.

Download full-text PDF

Source
http://dx.doi.org/10.2174/187152571103140120103302DOI Listing
September 2013
19 Reads

Publication Analysis

Top Keywords

resveratroloside cardioprotective
8
resveratrol resveratroloside
8
group received
8
cardioprotective resveratrol
8
myocardial infarct
4
infarct area
4
550±40% control
4
decrease myocardial
4
area 550±40%
4
statistically decrease
4
30-min ischemia
4
ischemia 120-min
4
reperfusion statistically
4
control group
4
group 407±44%
4
received resveratroloside
4
cardioprotective resveratroloside
4
resveratroloside detected
4
416±48% group
4
resveratrol 416±48%
4

Similar Publications